Search research articles
Contact Us
Filters
Showing results (241-250 of 299) with videos related to
Page
of 30
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2022
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection
Verena Krähling, Stephanie Erbar, Alexandra Kupke, et al.
Science (New York, N.Y.)
|
December 4, 2003
Phylogeny of the SARS coronavirus
Markus Eickmann, Stephan Becker, Hans-Dieter Klenk, et al.
Frontiers in Immunology
|
January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity
Ilka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
The Journal of Infectious Diseases
|
December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories
Marcus Panning, Thomas Laue, Stephan Olschlager, et al.
Nature Communications
|
September 21, 2021
Multi-level inhibition of coronavirus replication by chemical ER stress
Mohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, et al.
NPJ Vaccines
|
August 18, 2020
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
Helena Müller, Sarah Katharina Fehling, Jens Dorna, et al.
Archives of Virology
|
November 4, 2010
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
Jens H Kuhn, Stephan Becker, Hideki Ebihara, et al.
The Lancet. Infectious Diseases
|
October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Journal of Medicinal Chemistry
|
September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease
Mark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.
NPJ Vaccines
|
January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
Leonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 299) with videos related to
Sort By:
Page
of 30
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2022
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection
Verena Krähling, Stephanie Erbar, Alexandra Kupke, et al.
Science (New York, N.Y.)
|
December 4, 2003
Phylogeny of the SARS coronavirus
Markus Eickmann, Stephan Becker, Hans-Dieter Klenk, et al.
Frontiers in Immunology
|
January 3, 2025
MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity
Ilka Grewe, Monika Friedrich, Marie-Louise Dieck, et al.
The Journal of Infectious Diseases
|
December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories
Marcus Panning, Thomas Laue, Stephan Olschlager, et al.
Nature Communications
|
September 21, 2021
Multi-level inhibition of coronavirus replication by chemical ER stress
Mohammed Samer Shaban, Christin Müller, Christin Mayr-Buro, et al.
NPJ Vaccines
|
August 18, 2020
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
Helena Müller, Sarah Katharina Fehling, Jens Dorna, et al.
Archives of Virology
|
November 4, 2010
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
Jens H Kuhn, Stephan Becker, Hideki Ebihara, et al.
The Lancet. Infectious Diseases
|
October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Journal of Medicinal Chemistry
|
September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease
Mark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.
NPJ Vaccines
|
January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans
Leonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Page
of 30